로딩 중…
지수 로딩 중…
Inhibrx Biosciences, Inc.
INBX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$92.33-1.98%
2026-06-18
Price Chart
Inhibrx Biosciences, Inc.+507.07%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.35B |
| Revenue | $1M |
| Net Income | $-130M |
| Total Assets | $184M |
| Net Assets | $69M |
| Value | |
| P/B | 19.76x |
| FCF Yield | -9.74% |
| Profitability | |
| ROE | -189.89% |
| ROA | -70.77% |
| Op. Margin | -9465.46% |
| Revenue Growth | 550.00% |
| Earnings Growth | -108.30% |
| Financial Health | |
| Debt Ratio | 299.02% |
| Total Debt | $6M |
| FCF | $-132M |
| Cash | $162M |
| Current Ratio | 6.46x |
| Performance | |
| 1Y Return | 507.07% |
| 1M Return | -15.68% |
| From 52W High | -40.54% |
| 1Y MDD | -38.66% |
| Trading | |
| Volume | 277,011 shares |
| Trading Value | $26M |
| Per Share | |
| EPS | $-9.04 |
| BPS | $0.52 |